Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143403
Status:
COMPLETED
Last Update Posted:
2010-09-28
First Post:
2005-09-01
Brief Title:
Comparing Irinotecan and 5 FUFA To 5-FUFA After Resection Of Liver Metastases For Colorectal Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Multi-Centre Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FUFA Infusional Regimen To The Same 5-FUFA Infusional Regimen Alone As Adjuvant Treatment After Resection Of Liver Metastases For Colorectal Cancer
Status:
COMPLETED
Status Verified Date:
2010-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To see if Disease Free Survival DFS is improved when complete surgical resection of liver metastases R0 is followed by chemotherapy with CPT-11 and 5-FUFA as FOLFIRI regimen compared to 5-FUFA alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A5961076 | None | None | None |